Glaucoma Drop Aids Study
Part of Eyes & vision clinical trials.
This study looks at tools to help people use their glaucoma eyedrops correctly. You may be eligible if you've been on the same drops for 2 months and are a patient at Boston University Eye Associates.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been using the same glaucoma eyedrops for at least 2 months
- You are a patient at Boston University Eye Associates
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether insulin eye drops can safely help dry eye in people who also use eye drops for glaucoma. It may offer a new option if you have both conditions and your eye pressure is stable.
This Phase 1 study tests an insulin-based eye treatment to see if it’s safe and potentially helpful for people with glaucoma-related optic nerve damage. If you may be eligible, you’ll have a close eye exam and repeated vision testing, mainly focused on one study eye.
This trial tests an investigational eye drop called ASP2767 to see if it is safe and can help slow or prevent further vision loss in people with advanced glaucoma-related optic nerve damage.
This study looks at whether a common class of glaucoma eye drops (called prostaglandin analogues) can protect the nerve cells in the back of the eye. It may help people with certain types of glaucoma who have been stable on one type of eye drop for at least 3 years.
This trial tests if adding brimonidine eye drops can reduce eye redness caused by the glaucoma drops you are currently taking. It may help if you have been using netarsudil/latanoprost drops and have noticed redness.
This study looks at how certain glaucoma eye drops affect the surface of your eye. It tests a new implant that may reduce damage and improve comfort.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.